Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
164
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 139-160 Hetero hexamer : IID50102 Complex
Region 2zvv Y 139-141 disorder
Region 2zvv Y 142-158 order
Region 2zvv Y 159-160 disorder
Region 2zvv X 139-142 disorder
Region 2zvv X 143-153 order
Region 2zvv X 154-160 disorder
Seq 139-160 Hetero hexamer : IID00022 Complex
Region 5e0u F 139-142 disorder
Region 5e0u F 143-160 order
Region 5e0u E 139-141 disorder
Region 5e0u E 142-160 order
Region 5e0u D 139-142 disorder
Region 5e0u D 143-160 order
Seq 139-160 Hetero hexamer : IID50110 Complex
Region 2zvw P 139-142 disorder
Region 2zvw P 143-153 order
Region 2zvw P 154-160 disorder
Region 2zvw O 139-142 disorder
Region 2zvw O 143-153 order
Region 2zvw O 154-160 disorder
Region 2zvw N 139-142 disorder
Region 2zvw N 143-153 order
Region 2zvw N 154-160 disorder
Region 2zvw M 139-142 disorder
Region 2zvw M 143-153 order
Region 2zvw M 154-160 disorder
Region 2zvw L 139-142 disorder
Region 2zvw L 143-153 order
Region 2zvw L 154-160 disorder
Region 2zvw K 139-142 disorder
Region 2zvw K 143-153 order
Region 2zvw K 154-160 disorder
Region 2zvw J 139-142 disorder
Region 2zvw J 143-153 order
Region 2zvw J 154-160 disorder
Region 2zvw I 139-142 disorder
Region 2zvw I 143-153 order
Region 2zvw I 154-160 disorder
Seq 139-160 Hetero hexamer : IID00022 Complex
Region 4rjf F 139-142 disorder
Region 4rjf F 143-160 order
Region 4rjf D 139-141 disorder
Region 4rjf D 142-160 order
Region 4rjf B 139-140 disorder
Region 4rjf B 141-160 order
Region 1axc F 139-142 disorder
Region 1axc F 143-160 order
Region 1axc D 139-142 disorder
Region 1axc D 143-160 order
Region 1axc B 139-142 disorder
Region 1axc B 143-160 order
Seq ProS verified 141-160 Hetero hexamer : IID00022 Complex
Region 4rjf B 141-160 order
Region 4rjf D 142-160 order
Region 4rjf F 143-160 order
Region 1axc B 143-160 order
Region 1axc D 143-160 order
Region 1axc F 143-160 order
Seq ProS verified 142-158 Hetero hexamer : IID50102 Complex
Region 2zvv X 143-153 order
Region 2zvv Y 142-158 order
Seq ProS verified 142-160 Hetero hexamer : IID00022 Complex
Region 5e0u D 143-160 order
Region 5e0u E 142-160 order
Region 5e0u F 143-160 order
Seq ProS verified 143-153 Hetero hexamer : IID50110 Complex
Region 2zvw I 143-153 order
Region 2zvw J 143-153 order
Region 2zvw K 143-153 order
Region 2zvw L 143-153 order
Region 2zvw M 143-153 order
Region 2zvw N 143-153 order
Region 2zvw O 143-153 order
Region 2zvw P 143-153 order
80-80 Phosphothreonine; by LKB1
114-114 Phosphoserine; by GSK3-beta
145-145 Phosphothreonine; by PKA
146-146 Phosphoserine; by PKC and NUAK1
160-160 Phosphoserine; by PKC; in vitro
Prediction
ProS 77-80,112-116,145-161
Disorder 1-13,82-141,149-164
Function
Function in SwissProt
May be involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex. Inhibits DNA synthesis by DNA polymerase delta by competing with POLD3 for PCNA binding (PubMed:11595739). Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed:9106657).